9 Anti-platelet drugs: do they affect megakaryocytes?

Jean-Pierre Cazenave, Christian Gachet

Open source

DOI
10.1016/s0950-3536(97)80056-x
Published
1997-02
Container
Baillière's Clinical Haematology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0950-3536-97-80056-x,
  title = {9 Anti-platelet drugs: do they affect megakaryocytes?},
  author = {Jean-Pierre Cazenave and Christian Gachet},
  year = {1997},
  journal = {Baillière's Clinical Haematology},
  doi = {10.1016/s0950-3536(97)80056-x},
  url = {https://doi.org/10.1016/s0950-3536(97)80056-x}
}

RIS

TY  - JOUR
TI  - 9 Anti-platelet drugs: do they affect megakaryocytes?
AU  - Jean-Pierre Cazenave
AU  - Christian Gachet
PY  - 1997
JO  - Baillière's Clinical Haematology
DO  - 10.1016/s0950-3536(97)80056-x
UR  - https://doi.org/10.1016/s0950-3536(97)80056-x
ER  - 

APA

Cazenave, J., & Gachet, C. (1997). 9 Anti-platelet drugs: do they affect megakaryocytes?. Baillière's Clinical Haematology. https://doi.org/10.1016/s0950-3536(97)80056-x

Source records